These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 23152176)
1. Bezafibrate to prevent relapsing pancreatitis in WAGR syndrome. Diacono D; Fagbemi A; Puleston J; Banerjee I BMJ Case Rep; 2012 Nov; 2012():. PubMed ID: 23152176 [TBL] [Abstract][Full Text] [Related]
2. Management of hypertriglyceridaemic pancreatitis in the acute setting and review of literature. Samarasinghe S; Avari P; Meeran K; Cegla J BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567142 [TBL] [Abstract][Full Text] [Related]
3. [Bezafibrate in an infant with congenital generalized lipodystrophy and severe hypertriglyceridemia]. Araújo RS; Ramos Ade P; Borges Mde A Arq Bras Endocrinol Metabol; 2013 Nov; 57(8):653-8. PubMed ID: 24343636 [TBL] [Abstract][Full Text] [Related]
4. Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients. Fukushima M; Taniguchi A; Sakai M; Doi K; Nagata I; Nagasaka S; Tokuyama K; Nakai Y Diabetes Care; 2000 Feb; 23(2):259. PubMed ID: 10868845 [No Abstract] [Full Text] [Related]
5. Lymphocyte-suppressing effects of omega-3 fatty acids in bezafibrate-treated patients with isolated hypertriglyceridemia. Krysiak R; Gdula-Dymek A; Okopien B Eur J Intern Med; 2012 Sep; 23(6):e166-7. PubMed ID: 22863445 [No Abstract] [Full Text] [Related]
6. Omega-3 fatty acids enhance monocyte-suppressing effect of bezafibrate in patients with isolated hypertriglyceridemia. Krysiak R; Gdula-Dymek A; Okopien B Eur J Intern Med; 2012 Oct; 23(7):e171-2. PubMed ID: 22854277 [No Abstract] [Full Text] [Related]
7. Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial. Arbel Y; Klempfner R; Erez A; Goldenberg I; Benzekry S; Shlomo N; Fisman EZ; Tenenbaum A; Cardiovasc Diabetol; 2016 Jan; 15():11. PubMed ID: 26794137 [TBL] [Abstract][Full Text] [Related]
8. Serum homocysteine increases after therapy with fenofibrate or bezafibrate. Dierkes J; Westphal S; Luley C Lancet; 1999 Jul; 354(9174):219-20. PubMed ID: 10421307 [TBL] [Abstract][Full Text] [Related]
9. Delayed bezafibrate-induced angio-oedema in a 68-year-old man. Frendo M; Theuma R; Fava S Br J Clin Pharmacol; 2007 Oct; 64(4):560-1. PubMed ID: 17610533 [No Abstract] [Full Text] [Related]
10. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. Jonkers IJ; Smelt AH; Ledeboer M; Hollum ME; Biemond I; Kuipers F; Stellaard F; Boverhof R; Meinders AE; Lamers CH; Masclee AA Gut; 2003 Jan; 52(1):109-15. PubMed ID: 12477770 [TBL] [Abstract][Full Text] [Related]
11. [Plasmapheresis in the treatment of an acute pancreatitis due to hypertriglyceridemia]. Zborovszky EC; Santana-Cabrera L; Ramírez Rodríguez A; Díaz Mendoza C Med Clin (Barc); 2014 Mar; 142(6):282. PubMed ID: 24315744 [No Abstract] [Full Text] [Related]
12. Implication of fibrate therapy for homocysteine. Jonkers IJ; de Man FH; Onkenhout W; van der Laarse A; Smelt AH Lancet; 1999 Oct; 354(9185):1208. PubMed ID: 10513736 [No Abstract] [Full Text] [Related]
13. Antihypertensive mechanisms of lipid-lowering drugs: decoding the Rosetta stone's inscriptions'. Grassi G; Taddei S J Hypertens; 2001 Apr; 19(4):675-7. PubMed ID: 11330868 [No Abstract] [Full Text] [Related]
14. Hemostatic effects of omega-3 fatty acids in isolated hypertriglyceridemic patients treated with bezafibrate. Krysiak R; Okopien B Eur J Intern Med; 2012 Sep; 23(6):e168-9. PubMed ID: 22863446 [No Abstract] [Full Text] [Related]
15. Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial. Jonkers IJ; Mohrschladt MF; Westendorp RG; van der Laarse A; Smelt AH Am J Med; 2002 Mar; 112(4):275-80. PubMed ID: 11893366 [TBL] [Abstract][Full Text] [Related]
16. Coagulofibrinolytic assessment of effects of bezafibrate on hypertriglyceridemia in postmenopausal women. Ushiroyama T; Ikeda A; Higashio S; Ueki M Blood Coagul Fibrinolysis; 2000 Dec; 11(8):709-14. PubMed ID: 11132648 [TBL] [Abstract][Full Text] [Related]
17. Bezafibrate for the treatment of hypertriglyceridemia in HIV1-infected patients on highly active antiretroviral therapy. Geraix J; de Souza ME; Delatim FC; Pereira PC Braz J Infect Dis; 2006 Jun; 10(3):159-64. PubMed ID: 17568845 [TBL] [Abstract][Full Text] [Related]
18. The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia. Krysiak R; Gdula-Dymek A; Okopien B Eur J Clin Pharmacol; 2011 Nov; 67(11):1109-17. PubMed ID: 21630032 [TBL] [Abstract][Full Text] [Related]
19. Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy. de Man FH; Nieuwland R; van der Laarse A; Romijn F; Smelt AH; Gevers Leuven JA; Sturk A Atherosclerosis; 2000 Oct; 152(2):407-14. PubMed ID: 10998469 [TBL] [Abstract][Full Text] [Related]
20. Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry. Klempfner R; Erez A; Sagit BZ; Goldenberg I; Fisman E; Kopel E; Shlomo N; Israel A; Tenenbaum A Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):100-8. PubMed ID: 26957517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]